What about the control group? Provision of a lower-intensity intervention to control sites post-trial to improve bronchiolitis management in Australasian hospitals: A multi-method PREDICT study
Monday, April 27, 2026
8:00am - 10:00am ET
Victoria Ramsden, Murdoch Children's Research Institute, randwick, New South Wales, Australia; Franz E. Babl, The Royal Children's Hospital, Melbourne, Victoria, Australia; Libby Haskell, The University of Auckland, Auckland, Auckland, New Zealand; Sandy Middleton, Australian Catholic University, Sydney, New South Wales, Australia; Nicola Straiton, Australia Catholic University, Sydney, New South Wales, Australia; Ed Oakley, The Royal Children's Hospital, Melbourne, Victoria, Australia; Anna Lithgow, The Royal Darwin Hospital, Tiwi, Northern Territory, Australia; Alexandra Wallace, Waikato Hospital, Health New Zealand, Hamilton, Waikato, New Zealand; Mark H. Corden, Northern Health, Ascot Vale, Victoria, Australia; Sonja Crone, Te Whatu Ora Lakes, Health New Zealand, Rotorua, Bay of Plenty, New Zealand; Kate Curtis, University of Sydney, Sydney, New South Wales, Australia; Shane George, Griffith University and Gold Coast Health, Gold Coast, Queensland, Australia; Lambros Halkidis, Cairns Hospital, Cairns, Queensland, Australia; Kirsten Hrabar, ROYAL DARWIN HOSPITAL, Darwin, Northern Territory, Australia; Amit Kochar, Womens And Childrens Hospital, ADELAIDE, South Australia, Australia; Parag Tambe, Southland District Health Board, Invercargill, Southland, New Zealand; Peter H. Wilson, Australian Catholic University, Melbourne, Victoria, Australia; Stuart Dalziel, University of Auckland, Auckland, Auckland, New Zealand; Emma Tavender, Murdoch Children's Research Institute, Melbourne, Victoria, Australia